← Leaderboards
Tetsuhiro Harimoto
Columbia Univ New York Morningside
$497,051
Attributed
$497,051
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $138K · FY2020–25$200K$150K$100K$50K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$497,051 · 3
By mechanism
K00$267,500 · 1
K99$137,995 · 1
F99$91,556 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Novel Strategies”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Mark Marino · Venturewell$48,913,644
- Ted Ross · University Of Georgia$39,967,158
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Xinhua Li · Nano Terra, Inc.$29,432,783
Research focus
Novel StrategiesBacterial GenesGenesMouse ModelToxic EffectProductionEffective TherapyFeedbackGrowthMalignant NeoplasmsResponseSynthetic BiologyTreatment EfficacyTumorClinical TranslationCytotoxicEngineeringEnvironmentCancer TherapyBacteriaCellsColorectalColorectal CancerColorectal Neoplasms
Grant awards (6)
Engineered Living Materials as Programmable Therapeutic Implants for Pancreatic Cancer$137,995
K99 · FY2025 · CA · contact PI
Engineering tumor-targeting bacteria to sense and deliver therapeutics$93,078
K00 · FY2024 · CA · contact PI
Engineering tumor-targeting bacteria to sense and deliver therapeutics$88,627
K00 · FY2023 · CA · contact PI
Engineering tumor-targeting bacteria to sense and deliver therapeutics$85,795
K00 · FY2022 · CA · contact PI
Engineering tumor-targeting bacteria to sense and deliver therapeutics$46,036
F99 · FY2021 · CA · contact PI
Engineering tumor-targeting bacteria to sense and deliver therapeutics$45,520
F99 · FY2020 · CA · contact PI